Brno, Czechia

Vaclav Racansky

This inventor holds 1 USPTO granted patent. Top assignee: Peregrine Pharmaceuticals, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vaclav Racansky. Retrieved from https://idiyas.com/inventor/vaclav-racansky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Vaclav Racansky

Introduction

Vaclav Racansky is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. His innovative approach has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Vaclav Racansky holds a patent for a method of diagnosing by determining the formic acid to nicotinic acid ratio. This method is designed to assess whether a mammal should undergo medical investigation for cancerous or pre-cancerous conditions based on the levels of these acids in the blood. This groundbreaking patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Racansky is currently employed at Peregrine Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Vaclav Racansky has collaborated with talented individuals such as Jaroslav Koca and Yveta Germano. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Vaclav Racansky's contributions to medical diagnostics through his innovative patent demonstrate his significant impact on the field. His work continues to inspire advancements in cancer detection and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…